CN102872195B - 一种肉桂总多酚提取物的制备方法及其应用 - Google Patents
一种肉桂总多酚提取物的制备方法及其应用 Download PDFInfo
- Publication number
- CN102872195B CN102872195B CN201210434838.2A CN201210434838A CN102872195B CN 102872195 B CN102872195 B CN 102872195B CN 201210434838 A CN201210434838 A CN 201210434838A CN 102872195 B CN102872195 B CN 102872195B
- Authority
- CN
- China
- Prior art keywords
- extract
- chinese cassia
- cassia tree
- total polyphenols
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims abstract description 126
- 241000522254 Cassia Species 0.000 title claims abstract description 116
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 108
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 108
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 239000011347 resin Substances 0.000 claims abstract description 79
- 229920005989 resin Polymers 0.000 claims abstract description 79
- 239000012535 impurity Substances 0.000 claims abstract description 29
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 claims abstract description 23
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 claims abstract description 23
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 238000000605 extraction Methods 0.000 claims abstract description 15
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 claims abstract description 11
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940117916 cinnamic aldehyde Drugs 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 239000008187 granular material Substances 0.000 claims abstract description 5
- 229940023488 pill Drugs 0.000 claims abstract description 5
- 239000006187 pill Substances 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- 239000007935 oral tablet Substances 0.000 claims abstract description 3
- 229940096978 oral tablet Drugs 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 77
- 239000000243 solution Substances 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 239000002250 absorbent Substances 0.000 claims description 30
- 230000002745 absorbent Effects 0.000 claims description 30
- 239000003814 drug Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 19
- 239000012141 concentrate Substances 0.000 claims description 17
- 239000003480 eluent Substances 0.000 claims description 16
- 238000000746 purification Methods 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 15
- 238000010298 pulverizing process Methods 0.000 claims description 14
- 239000013049 sediment Substances 0.000 claims description 14
- 239000000725 suspension Substances 0.000 claims description 14
- 238000010790 dilution Methods 0.000 claims description 13
- 239000012895 dilution Substances 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 12
- 230000028161 membrane depolarization Effects 0.000 claims description 11
- 238000002791 soaking Methods 0.000 claims description 8
- 238000005325 percolation Methods 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 238000009792 diffusion process Methods 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 238000001179 sorption measurement Methods 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 4
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 claims description 3
- 208000002249 Diabetes Complications Diseases 0.000 claims description 3
- 206010012655 Diabetic complications Diseases 0.000 claims description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 14
- 239000003826 tablet Substances 0.000 abstract description 6
- 239000007902 hard capsule Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000003405 delayed action preparation Substances 0.000 abstract description 2
- 239000007937 lozenge Substances 0.000 abstract description 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 2
- 239000007901 soft capsule Substances 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 13
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 239000003463 adsorbent Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000003472 antidiabetic agent Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 241000723347 Cinnamomum Species 0.000 description 4
- 235000017803 cinnamon Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 229940125708 antidiabetic agent Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- WGFLJEFKPRMWSU-UHFFFAOYSA-N Cinnamoside Chemical compound C1C(O)(C)C(=C=CC(=O)C)C(C)(C)CC1OC1C(O)C(O)C(O)C(COC2C(C(O)(CO)CO2)O)O1 WGFLJEFKPRMWSU-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000005411 Van der Waals force Methods 0.000 description 2
- 230000003178 anti-diabetic effect Effects 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- ZMQAAUBTXCXRIC-UHFFFAOYSA-N safrole Chemical compound C=CCC1=CC=C2OCOC2=C1 ZMQAAUBTXCXRIC-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004155 insulin signaling pathway Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 238000000874 microwave-assisted extraction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210434838.2A CN102872195B (zh) | 2012-11-05 | 2012-11-05 | 一种肉桂总多酚提取物的制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210434838.2A CN102872195B (zh) | 2012-11-05 | 2012-11-05 | 一种肉桂总多酚提取物的制备方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102872195A CN102872195A (zh) | 2013-01-16 |
CN102872195B true CN102872195B (zh) | 2016-05-18 |
Family
ID=47473865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210434838.2A Expired - Fee Related CN102872195B (zh) | 2012-11-05 | 2012-11-05 | 一种肉桂总多酚提取物的制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102872195B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104274528B (zh) * | 2013-07-02 | 2018-04-13 | 上海中医药大学 | 一种具有免疫抑制活性的桂皮多酚提取物及其制备方法和应用 |
CN107496269A (zh) * | 2017-10-18 | 2017-12-22 | 广东丸美生物技术股份有限公司 | 一种肉桂树皮提取物及其制备方法与在化妆品中的应用 |
CN110215475B (zh) * | 2019-06-14 | 2021-10-26 | 华南理工大学 | 一种具有抑制肠癌细胞增殖活性的桂枝多酚及其制备方法与应用 |
CN115192631A (zh) * | 2022-08-29 | 2022-10-18 | 北京明阳华夏科技有限公司 | 一种肉桂提取物的制备方法及其肉桂提取物与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102274244A (zh) * | 2011-07-14 | 2011-12-14 | 中国药科大学 | 一种肉桂多酚提取物、其制备方法及其用途 |
-
2012
- 2012-11-05 CN CN201210434838.2A patent/CN102872195B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102274244A (zh) * | 2011-07-14 | 2011-12-14 | 中国药科大学 | 一种肉桂多酚提取物、其制备方法及其用途 |
Non-Patent Citations (1)
Title |
---|
肉桂多酚的研究进展;李诚,等;《亚太传统医药》;20110930;第7卷(第9期);第169-172页 * |
Also Published As
Publication number | Publication date |
---|---|
CN102872195A (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101463061B (zh) | 三七中人参皂苷Rg1、Rb1及其总皂苷的制备方法 | |
CN100998614A (zh) | 一种灵芝孢子粉的萃取方法及其制品的深加工技术 | |
CN101585885A (zh) | 一种玉竹多糖的制备方法 | |
CN107595893A (zh) | 一种经酶处理的中药饮片及其制备方法 | |
CN112870236B (zh) | 一种黄蜀葵花黄酮类有效部位及其制备方法与应用 | |
CN102872195B (zh) | 一种肉桂总多酚提取物的制备方法及其应用 | |
WO2008007063A2 (en) | Anti-obesity product and it's method of preparation | |
CN103720892A (zh) | 含有淫羊藿的中药组合物及其制备方法 | |
CN103169788A (zh) | 大枣叶提取物及其在制备防治肝损伤药物及保健食品中的应用 | |
CN102119964A (zh) | 一种预防和治疗冠心病心绞痛的提取物,它们的制备方法及用途 | |
CN105267257A (zh) | 一种银杏叶提取物的制备方法 | |
CN107519227A (zh) | 一种金银花组合物颗粒及其制备方法 | |
CN101982184B (zh) | 一种蒲公英提取物的制备方法 | |
CN101254217B (zh) | 一种红豆杉树可再生部分的提取物的制备方法及该提取物在制备口服抗癌药物中的应用 | |
CN108434191A (zh) | 一种具有减肥降糖降脂作用的组合物及其制备方法 | |
CN108077727A (zh) | 一种降血脂的荷叶苦瓜植物淀粉食品及其制备方法 | |
CN112159451A (zh) | 一种绞股蓝皂苷提取物及其制备方法 | |
CN106361811B (zh) | 一种通脉药物组合物及其制备方法 | |
CN112641826B (zh) | 一种紫苏籽提取物及其制备方法、应用 | |
CN108497246A (zh) | 一种植物减肥功能饮料及其制备方法 | |
CN104725400B (zh) | 一种从辣木根部提取辣木素的方法 | |
CN102000126B (zh) | 银杏黄酮片及其制备方法 | |
CN102319273A (zh) | 北美盐角草活性总皂苷提取物及其制备方法和瘦身减肥的用途 | |
CN110123859B (zh) | 具有防治肝损伤的菊叶提取物及其应用 | |
CN101167796B (zh) | 一种防治心脑血管疾病的红曲和丹参组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 300384 Tianjin Huayuan Industrial Zone Haitai development six road 6 C Haitai green industry base 502 Applicant after: TIANJIN JUXING KANGHUA MEDICAL TECHNOLOGY CO.,LTD. Address before: Three road 300384 Tianjin Haitai Huayuan Industrial Zone Xiqing District Branch No. 1 Building 2 901 4 Applicant before: TIANJIN JUXING KANGHUA MEDICAL TECHNOLOGY CO.,LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Hualin Inventor before: Lu Xin Inventor before: Wang Chunli |
|
PP01 | Preservation of patent right |
Effective date of registration: 20190704 Granted publication date: 20160518 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20220704 Granted publication date: 20160518 |
|
PD01 | Discharge of preservation of patent | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160518 Termination date: 20191105 |
|
CF01 | Termination of patent right due to non-payment of annual fee |